Farther Finance Advisors LLC Raises Position in HCA Healthcare, Inc. (NYSE:HCA)

Farther Finance Advisors LLC increased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 28.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,157 shares of the company’s stock after purchasing an additional 255 shares during the quarter. Farther Finance Advisors LLC’s holdings in HCA Healthcare were worth $470,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in the business. Capital Advisors Inc. OK raised its position in HCA Healthcare by 4.8% in the 3rd quarter. Capital Advisors Inc. OK now owns 1,172 shares of the company’s stock worth $476,000 after purchasing an additional 54 shares during the period. Stephens Inc. AR increased its position in shares of HCA Healthcare by 1.0% in the third quarter. Stephens Inc. AR now owns 8,852 shares of the company’s stock valued at $3,598,000 after acquiring an additional 91 shares during the period. Deroy & Devereaux Private Investment Counsel Inc. increased its position in shares of HCA Healthcare by 0.3% in the third quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 118,881 shares of the company’s stock valued at $48,317,000 after acquiring an additional 395 shares during the period. Fairfield Financial Advisors LTD increased its position in shares of HCA Healthcare by 8.1% in the third quarter. Fairfield Financial Advisors LTD now owns 1,684 shares of the company’s stock valued at $685,000 after acquiring an additional 126 shares during the period. Finally, AustralianSuper Pty Ltd increased its position in shares of HCA Healthcare by 118.5% in the third quarter. AustralianSuper Pty Ltd now owns 35,493 shares of the company’s stock valued at $14,425,000 after acquiring an additional 19,247 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 5.0 %

NYSE:HCA opened at $348.50 on Thursday. The company’s 50 day moving average price is $391.18 and its 200-day moving average price is $355.72. HCA Healthcare, Inc. has a 52 week low of $226.48 and a 52 week high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The stock has a market cap of $88.28 billion, a price-to-earnings ratio of 15.65, a PEG ratio of 1.39 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.76%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on HCA shares. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. Leerink Partners boosted their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Morgan Stanley began coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. Finally, Barclays boosted their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 24th. Five investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $379.39.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.